article thumbnail

Pharmacies Selling PSE: Remember to Train Employees and Self-Certify

The FDA Law Blog

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).

article thumbnail

“Thaw Out” with Pharma Thought Leaders at the 2024 Puerto Rico Pharmaceutical Summit: HPM Directors to Discuss Drug Approvals and Puerto Rico “Exportation” Best Practices

The FDA Law Blog

This day-long (FREE) seminar is a must-attend event for anyone in the pharmaceutical sector interested in understanding the “ins and outs” of doing business in the Territory, as well as an opportunity to interact with those who already have a keen understanding of doing business in Puerto Rico. HPM is a co-sponsor of the event.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HP&M’s Larry Houck A Panelist at FDLI’s Cannabis Regulation Conference

The FDA Law Blog

Last August the Food and Drug Administration (“FDA”)/Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule cannabis from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. April 4th and 5th, is an in-person and virtual event.

article thumbnail

Vyvanse generic availability, cost, and dosage

The Checkup by Singlecare

It is a Drug Enforcement Administration (DEA) controlled substance in the Schedule II category. Non-amphetamine-based ADHD treatments, such as Strattera , are not controlled substances. Food and Drug Administration (FDA) in 2007 for treatment and symptom control in ADHD. Vyvanse was initially approved by the U.S.

Dosage 92
article thumbnail

Democratic Lawmakers Advocate for Prompt Decontrol of Marijuana

The FDA Law Blog

Later Democratic lawmakers, eleven senators and ten members of Congress, also penned a letter to Administrator Milgram and Attorney General Merrick Garland imploring DEA to not only “promptly remove marijuana” from schedule I of the Controlled Substances Act (“CSA”), but to deschedule it altogether. April 24, 2024.

article thumbnail

Focalin vs. Vyvanse: Differences, Similarities, and Which One is Better For You

The Checkup by Singlecare

It’s a Schedule II controlled substance that’s approved by the U.S. Like Focalin, Vyvanse is also a Schedule II controlled substance approved by the FDA to treat ADHD. They have a high potential for abuse and misuse, which can lead to substance use disorder, overdose, and even death. RELATED: What is Focalin?

article thumbnail

ACI’s 42nd FDA Boot Camp – New York City Edition

The FDA Law Blog

The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law. You can access the conference brochure and sign up for the event here (or by emailing customerservice@americanconference.com or by calling 1-888-224-2480). FDA Law Blog is a conference media partner.

FDA 59